Discontinuation report LOSEC 10 MG
| Report ID | 99357 |
| Drug Identification Number | 02230737 |
| Brand name | LOSEC 10 MG |
| Common or Proper name | omeprazole magnesium delayed realease tablets |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OMEPRAZOLE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 1 X15 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-11-16 |
| Remaining supply date | 2019-11-16 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-11-20 | French | Compare |
| v2 | 2019-11-20 | English | Compare |
| v1 | 2019-11-20 | English | Compare |
Showing 1 to 3 of 3